SCHEMBL29430280

SCHEMBL29430280

CCCOc1ccc(N(CC(=O)N(C)C)C(C)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 1/20 0.47
MCL1 Q07820 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.43
PLK1 P53350 1/20 0.43
LMNA P02545 3/20 0.43
MAPK1 P28482 1/20 0.43
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29649659 0.94 CYP2D6 (0.46)
SCHEMBL30352496 0.90 ALDH1A1 (0.52) ALDH1A1MAPTKDM4EPLK1LMNA
SCHEMBL30278608 0.82 TSPO (0.48) ALDH1A1MAPTTSHRRAB9AMAPK1
SCHEMBL30065200 0.78 TSPO (0.51) ALDH1A1MAPTKDM4EMCL1HSD17B10
SCHEMBL29390820 0.77 ALDH1A1 (0.45) ALDH1A1MAPTKDM4ERAB9APLK1
SCHEMBL4496895 0.75 ALDH1A1 (0.41) ALDH1A1MAPTTSHRRAB9AL3MBTL1
Phenylacetylglycine Dimethylamide SCHEMBL6056919 0.75 ALDH1A1 (0.49) ALDH1A1TSHRRAB9AL3MBTL1TP53
SCHEMBL10274491 0.74 ALDH1A1 (0.52) ALDH1A1MAPTKDM4ETSHRRAB9A
SCHEMBL6908413 0.73 LMNA (0.40) ALDH1A1MAPTHSD17B10L3MBTL1LMNA
SCHEMBL29521154 0.72 L3MBTL1 (0.52) ALDH1A1MAPTTSHRRAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12529705-B2 Method for detecting the presence and quantity of the LRP8 receptor and of its proteolytic fragments, detection kit and related antibodies Claudio, Russo (IT) 2026-01-20 US disclosed
EP-3903107-B1 METHOD FOR DETECTING THE PRESENCE AND QUANTITY OF THE LRP8 RECEPTOR AND OF ITS PROTEOLYTIC FRAGMENTS, DETECTION KIT AND RELATED ANTIBODIES RUSSO CLAUDIO (IT) 2025-01-29 EP disclosed
US-20220074957-A1 METHOD FOR DETECTING THE PRESENCE AND QUANTITY OF THE LRP8 RECEPTOR AND OF ITS PROTEOLYTIC FRAGMENTS, DETECTION KIT AND RELATED ANTIBODIES Russo, Claudio (IT) 2022-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529705-B2 Method for detecting the presence and quantity of the LRP8 receptor and of its proteolytic fragments, detection kit and related antibodies BACE1, BACE2, APH1A ALDH1A1 4335/4885MAPT 783/4885KDM4E 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.